Delivery Order SPE2DB22D2009-SPE2DB24FL9LY
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,086.08 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,451.78 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules to support military healthcare programs. The contract has an ultimate completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,505.54 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has a completion date of December 9, 2022 and was awarded on December 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $2,682.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. It has a firm fixed price and an ultimate completion date of May 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) for the delivery of LINZESS 145 MCG capsules. The $11,706.10 firm fixed price delivery order contract has a completion date of June 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,000.84 firm fixed-price contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a prescription medication. The contract has an ultimate completion date of February 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,892.02 firm fixed price delivery order is for the supply of 4565285737 LINZESS 72 MCG capsules. The contract has an ultimate completion date of July 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,192.33 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,411.52 firm fixed-price delivery order contract is for the supply of LINZESS 72 MCG CAPSULE, with a performance period running through November 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.98 fixed-price delivery order is for the supply of LINZESS 145 MCG capsules and has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL9LYDelivery Order
This federal contract award, with ID SPE2DB22D2009|SPE2DB24FL9LY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,326.95 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 5/1/24 |